tag:blogger.com,1999:blog-16207375070656001232011-11-27T16:56:39.458-08:00pharmaceutical news,pharmaceutical sites, pharmaceutical links,pharmaceutical company,pharmaceutical journals,pharmaceuticals,pharma,drug,pharmaceutical technology,pharmaceutical jobs,biotechnology and healthcare,industry sectors,pharmaceutical industry,pharmaceutical reports,biotechnology reports,biotechnology news,biotechnology company,biotechnology reports,healthcare industry,healthcare news,healthcare company,healthcare reports,industry news,industry research,company researchPharmaMicsnoreply@blogger.comBlogger7991100tag:blogger.com,1999:blog-1620737507065600123.post-30137283449748513832010-11-25T22:44:00.000-08:002010-11-25T22:56:30.759-08:00

A daily dose of antiretroviral medication lowered the risk of contracting HIV by more than 40% among men who have sex with men, according to a study published Tuesday in the New England Journal of Medicine, the New York Times reports.The results of the study -- nicknamed iPrEx -- "are the best news in the AIDS field in years" and "could change the battle" against HIV/AIDS, according to the Times

PharmaMicsnoreply@blogger.com0tag:blogger.com,1999:blog-1620737507065600123.post-18241567835136502872010-11-25T22:31:00.000-08:002010-11-25T22:41:46.094-08:00

"While more research is needed with larger numbers of women and their babies, these results are reassuring to women who want to give their babies all the benefits of breastfeeding but also need to remain on their epilepsy medications to avoid devastating seizures," said study author Kimford Meador, MD, of Emory University in Atlanta and a Fellow of the American Academy of Neurology (AAN).The

PharmaMicsnoreply@blogger.com0tag:blogger.com,1999:blog-1620737507065600123.post-65743125819413240472010-11-25T20:35:00.000-08:002010-11-25T22:04:37.197-08:00

Babies born to women who took a popular class of heartburn drugs while they were pregnant did not appear to have any heightened risk of birth defects, a large Danish study finds.This class of drugs, known as proton-pump inhibitors (PPIs), include blockbusters such as Prilosec (omeprazole), Prevacid (lansoprazole) and Nexium (esomeprazole). All were available by prescription-only during most of

PharmaMicsnoreply@blogger.com0tag:blogger.com,1999:blog-1620737507065600123.post-84710122283330976702010-09-17T09:59:00.000-07:002010-09-17T10:05:45.801-07:00

By probing deeper into the biological mechanisms that go awry in melanoma, scientists have come up with an experimental drug that has had an effect in a surprising number of patients with advanced melanoma.The drug, PLX4032, just completed a phase 1 clinical trial in which 81 percent of participants with a particular gene mutation had a partial response, meaning at least some shrinkage of the

PharmaMicsnoreply@blogger.com0tag:blogger.com,1999:blog-1620737507065600123.post-83986893381063044862010-09-17T09:46:00.000-07:002010-09-17T09:58:32.879-07:00

Myelofibrosis is a rare but serious disorder in which the bone marrow is replaced by scar tissue. There is no currently approved treatment for the disease, but a phase I/II clinical study of an experimental drug produced by Incyte Corp. of Delaware may possibly lead to the first medical option to reduce spleen size.One of the primary symptoms of myelofibrosis is an enlarged spleen. Because the

PharmaMicsnoreply@blogger.com1tag:blogger.com,1999:blog-1620737507065600123.post-69090671186547902592010-09-15T07:05:00.000-07:002010-09-15T07:16:29.433-07:00

A major drug trial has brought scientists closer to making a drug that could prevent thousands of deaths from heart attacks.From the past six years, international clinical trials have been going on a new drug, ticagrelor.The new findings have revealed that the platelet function in patients taking ticagrelor recovered much quicker after the drug is stopped, compared to the current gold standard

PharmaMicsnoreply@blogger.com0tag:blogger.com,1999:blog-1620737507065600123.post-12712784814316332372010-09-15T06:56:00.000-07:002010-09-15T07:01:51.107-07:00

The Food and Drug Administration said Tuesday that it has approved a new drug to treat gout in patients who do not respond to existing therapy. The drug is called Krystexxa and is manufactured by Savient Pharmaceuticals Inc. of East Brunswick, N.J. The FDA had rejected the drug in August of 2009 because of manufacturing problems.In a letter to the company then, the agency said that the potential

PharmaMicsnoreply@blogger.com0tag:blogger.com,1999:blog-1620737507065600123.post-26482440219392413902010-09-15T06:46:00.000-07:002010-09-15T06:55:21.563-07:00

Scientists from the Singapore Immunology Network (SIgN) of Singapore’s Agency of Science, Technology and Research’s (A*STAR) led by Dr Laurent Renia have made a breakthrough concerning a drug that is effective against malaria.Their work, carried out with industry leader Novartis, the Swiss Tropical and Public Health Institute, and The Scripps Research Institute, was published in top scientific

PharmaMicsnoreply@blogger.com0tag:blogger.com,1999:blog-1620737507065600123.post-63405703091053189322010-09-14T06:14:00.000-07:002010-09-14T06:20:16.687-07:00

Patients with multidrug-resistant TB (MDR-TB) given a new anti-TB drug -- TMC207 -- combined with a background regimen, responded almost twice as fast as those on placebo with the background regimen, a researcher reported here.Final results from the first part of a stage IIb trial among 47 patients, found the median time to culture conversion was 11 weeks for those treated for eight weeks with

PharmaMicsnoreply@blogger.com0tag:blogger.com,1999:blog-1620737507065600123.post-31072865093795455072010-09-14T05:46:00.000-07:002010-09-14T06:09:44.873-07:00

Patients taking AstraZeneca Plc’s cholesterol-lowering medicine Crestor (Rosuvastatin) in a study were less likely to develop pneumonia, a finding that potentially will broaden use of such drugs.The result supports earlier research suggesting drugs in this class, called statins, prevent deaths from pneumonia. The latest study, an analysis of a 17,000-person clinical trial that ended in 2008, was

PharmaMicsnoreply@blogger.com0tag:blogger.com,1999:blog-1620737507065600123.post-56772167479728541872010-09-13T03:34:00.000-07:002010-09-13T03:42:04.173-07:00

GlaxoSmithKline’s (GSK) diabetes drug Avandia is once again under regulatory scrutiny—this time it’s in Europe where the European Medicines Agency met to discuss whether Avandia should continue to be marketed. The agency in a press statement said that no final decision has been made about the drug.It said it has further questions for GSK before deciding whether and what action needs to be taken.

PharmaMicsnoreply@blogger.com0tag:blogger.com,1999:blog-1620737507065600123.post-78711662875054576762010-09-13T03:27:00.000-07:002010-09-13T03:32:01.724-07:00

Novartis AG said an experimental meningitis B vaccine met the goals of a late-stage clinical study.The vaccine, called 4CMenB, achieved a “robust immune response” in the study of more than 3,600 infants, the Basel, Switzerland-based company said today in an e-mailed statement. The drug also had “an acceptable” side-effect profile, the company said.Novartis expects the results of additional

PharmaMicsnoreply@blogger.com0tag:blogger.com,1999:blog-1620737507065600123.post-18658589913189721932010-09-13T03:19:00.000-07:002010-09-13T03:22:12.708-07:00

Tens or even hundreds of thousands of Americans are having coronary artery angioplasty and stenting every year when they should be having bypass grafts, and the result is an extra 5,000 or more deaths annually, researchers said Sunday.Patients and cardiologists frequently prefer angioplasty and the insertion of a stent to keep arteries open because it is quicker and easier; patients go home

PharmaMicsnoreply@blogger.com0tag:blogger.com,1999:blog-1620737507065600123.post-12120648115163098602010-09-12T00:36:00.000-07:002010-09-12T00:42:17.846-07:00

A commonly used chemotherapy drug may offer a new lifeline to sufferers of one of the most deadly cancers, research has shown.Trial results suggest that the drug 5-fluorouracil (5-FU) is an effective alternative for pancreatic cancer patients who fail to respond to standard treatment.They also raise hopes of providing better therapy by combining the two drugs.A study now under way is looking at

PharmaMicsnoreply@blogger.com0tag:blogger.com,1999:blog-1620737507065600123.post-75628105699623548352010-09-12T00:16:00.000-07:002010-09-12T00:29:10.197-07:00

A strange drug, the premier in its class, gives added blood sugar dominate to mobile vulgus with category 2 diabetes who are already enchanting the glucose-lowering medication metformin.The budding agent, dapagliflozin, which also helped patients squander weight, is novel in that it does not produce directly on the body’s insulin mechanisms, according to a inspect appearing in the June 26 issue

PharmaMicsnoreply@blogger.com0tag:blogger.com,1999:blog-1620737507065600123.post-14179212104471162372010-09-10T11:58:00.000-07:002010-09-10T12:02:04.714-07:00

A research team has identified a small molecule that helps human cells get rid of the misfolded, disfigured proteins implicated in Alzheimer's disease and other neurodegenerative ailments.potential drug could have applications for other conditions as well.Cells create and discard proteins continuously, a process that relies on a balance between the speed with which new proteins are created and

PharmaMicsnoreply@blogger.com0tag:blogger.com,1999:blog-1620737507065600123.post-84324060921032223722010-09-10T11:52:00.000-07:002010-09-10T11:56:50.000-07:00

The newest form of emergency contraceptive, ellaOne, was approved August 13 by the U.S. Food and Drug Administration.Although the new drug has been around since fall of 2009 in select European countries, it was not introduced to the United States until June 2010.The new drug is a type of emergency contraceptive pill that allows a woman up to five days after sexual intercourse to consume the

PharmaMicsnoreply@blogger.com0tag:blogger.com,1999:blog-1620737507065600123.post-34281797137150777322010-09-10T11:40:00.000-07:002010-09-10T11:43:12.683-07:00

Researchers from the John Theurer Cancer Center at Hackensack University Medical Center played an important role in a study that led to the Food & Drug Administration's (FDA) recent fast tracking of ipilimumab, a promising treatment for metastatic melanoma.The FDA based its decision largely on the results of a pivotal study published in the New England Journal of Medicine on August 19, 2010 - the

PharmaMicsnoreply@blogger.com0tag:blogger.com,1999:blog-1620737507065600123.post-66546271185434035232010-05-24T23:17:00.000-07:002010-05-24T23:20:43.048-07:00

Tablets, insertable rings and dissolving films can effectively deliver drugs to help protect women and perhaps men from infection with the AIDS virus, researchers reported on Monday.They also found evidence that using such an approach -- called a microbicide -- may help overcome some of the risks of drug resistance that can come with taking pills to prevent infection.Here are some of the findings

PharmaMicsnoreply@blogger.com5tag:blogger.com,1999:blog-1620737507065600123.post-33496849827419961322010-05-24T23:02:00.000-07:002010-05-24T23:15:35.129-07:00

Medical tradition says that the beta blockers used to treat heart disease shouldn't be given to people who also have severe lung disease, but a new Dutch study suggests the tradition is wrong.A study of more than 2,200 people with chronic obstructive pulmonary disease (COPD), a diagnosis that includes emphysema and chronic bronchitis, found better survival among those given beta blockers than

PharmaMicsnoreply@blogger.com0tag:blogger.com,1999:blog-1620737507065600123.post-80819092660510487612010-05-20T13:20:00.000-07:002010-05-20T13:22:47.086-07:00

Merck & Co. and Cardiome Pharma Corp. said Friday that their drug candidate Brinavess met its goal in a late-stage clinical study, as it was better at restoring a steady heartbeat than an older drug use for the same purpose.The trial compared Brinavess to the standard drug, amiodarone, as a treatment for atrial fibrillation. Atrial fibrillation is a condition in which the upper chambers of the

PharmaMicsnoreply@blogger.com0tag:blogger.com,1999:blog-1620737507065600123.post-86560342969482685572010-05-20T13:12:00.000-07:002010-05-20T13:18:55.501-07:00

The first human clinical trials have started on a new drug developed to treat infections caused by the hepatitis C virus.The medication, taken orally, was first prepared at the Welsh School of Pharmacy at Cardiff University in 2008.Laboratory tests showed it killed 90% of the virus at very low concentration.Trials in healthy volunteers to assess the drug's safety are being held before its

PharmaMicsnoreply@blogger.com0tag:blogger.com,1999:blog-1620737507065600123.post-29616236514628665922010-05-20T13:02:00.000-07:002010-05-20T13:05:37.175-07:00

The introduction of the first rotavirus vaccine in the United States in 2006 led to sharp reductions in hospitalizations for gastroenteritis, an inflammation of the stomach and intestines that is marked by diarrhea and dehydration, researchers reported Wednesday. Rotavirus is one of the leading causes of gastroenteritis and was thought to be the cause of an estimated 55,000 to 70,000

PharmaMicsnoreply@blogger.com0tag:blogger.com,1999:blog-1620737507065600123.post-50278151238330280192010-05-20T12:55:00.000-07:002010-05-20T13:00:03.952-07:00

Pharmaceutical company Sanofi-Aventis Wednesday said it has initiated a Phase IIIb trial of Multaq in over 10 thousand patients with permanent atrial fibrillation or abnormal heart rhythm. The Paris, France-based company’s study is focused on assessing the potential clinical benefit of the drug in reducing major adverse cardiovascular events, and it expects first patient enrollment to begin in

PharmaMicsnoreply@blogger.com0tag:blogger.com,1999:blog-1620737507065600123.post-50160956912707555492010-05-20T12:43:00.000-07:002010-05-20T12:54:11.792-07:00

Brain plaques, long considered the chief killer of brain cells and the cause of Alzheimer's disease, may actually play a protective role under a new theory that is changing the way researchers think about the disease.Instead of sticky plaques, free-floating bits of a toxic protein called amyloid beta may be what's killing off brain cells in Alzheimer's patients, U.S. researchers say.If the theory

PharmaMicsnoreply@blogger.com0tag:blogger.com,1999:blog-1620737507065600123.post-52389481249076749492010-05-14T00:42:00.000-07:002010-05-14T00:54:50.574-07:00

Scientists have developed a new type of drug designed to kill non-Hodgkin lymphoma tumour cells.The breakthrough could lead to potential non-toxic therapies for cancer patients.The researchers, including Dr. Ari Melnick, of Weill Cornell Medical College, Dr. Alexander MacKerell, of the University of Maryland and Dr. Gilbert Prive, of the University of Toronto, have identified a drug that targets

PharmaMicsnoreply@blogger.com0tag:blogger.com,1999:blog-1620737507065600123.post-15307422367087436902010-05-14T00:22:00.000-07:002010-05-14T00:36:27.218-07:00

Biopharmaceutical company Achillion Pharmaceuticals Inc. said Tuesday that an additional preliminary data from its Phase 1b clinical trial of HCV Protease Inhibitor demonstrated positive results, with meaningful reductions in Hepatitis observed, and accompanied by continued safety and tolerability levels. Following the disclosure, the company's share were up 17.37% in the after hours

PharmaMicsnoreply@blogger.com0tag:blogger.com,1999:blog-1620737507065600123.post-63943943333244985692010-05-14T00:12:00.000-07:002010-05-14T00:22:12.507-07:00

A new drug may make getting around easier for the 2.5 million people worldwide afflicted with multiple sclerosis. It is the first medication to specifically target walking challenges faced by MS patients.In January, the U.S. Food and Drug Administration approved Ampyra (dalfampridine) as an oral medication to improve walking in people with MS. It has been available by prescription since March 1.

PharmaMicsnoreply@blogger.com0tag:blogger.com,1999:blog-1620737507065600123.post-69960227231579552302010-05-14T00:05:00.000-07:002010-05-14T00:12:26.776-07:00

Tuberculosis (TB) has been present in humans since ancient times. The origins of the disease date back to the first domestication of cattle, and skeletal remains show prehistoric humans (4,000 B.C.) had TB. Although relatively rare in the United States, it is the single leading bacterial cause of death worldwide. Approximately 8 million people are infected each year and 2 million people die from

PharmaMicsnoreply@blogger.com0tag:blogger.com,1999:blog-1620737507065600123.post-35731147347516113012010-05-13T23:59:00.000-07:002010-05-14T00:05:40.745-07:00

Cleveland BioLabs, Inc. Monday announced that dosing of healthy volunteers was completed in the second human safety study for CBLB502, a drug under development for the treatment of Acute Radiation Syndrome (ARS).CBLB502 is being developed by Cleveland BioLabs under the U.S. Food and Drug Administration's Animal Efficacy Rule to treat ARS or radiation poisoning from any exposure to radiation such

PharmaMicsnoreply@blogger.com0tag:blogger.com,1999:blog-1620737507065600123.post-64539859253109071072010-05-13T23:50:00.000-07:002010-05-13T23:57:12.123-07:00

More than 113 million prescriptions are written every year for proton pump inhibitors, drugs such as Prilosec or Nexium that Americans take to treat ulcers or other problems affecting the stomach or esophagus. But more than half the time these acid-reducing drugs are overprescribed for less serious heartburn or indigestion, according to research cited in tomorrow's Archives of Internal

PharmaMicsnoreply@blogger.com0tag:blogger.com,1999:blog-1620737507065600123.post-46797343146747500972010-05-10T13:04:00.000-07:002010-05-10T13:17:51.397-07:00

Newron Pharmaceuticals SpA, a research and development company focused on novel CNS and pain therapies, has announced that the topline top-line results of its Serena study, a phase-IIb/III study of ralfinamide in patients with at least moderate Neuropathic Low Back Pain (NLBP) failed to show any significant difference between ralfinamide and placebo.The 12-week Serena study enrolled 411 patients

PharmaMicsnoreply@blogger.com0tag:blogger.com,1999:blog-1620737507065600123.post-31045545705215306852010-05-10T12:58:00.001-07:002010-05-10T13:04:14.366-07:00

A drug currently approved to treat erectile dysfunction could significantly improve the delivery of the anti-cancer drug Herceptin to certain hard-to-treat brain tumours, according to a new study at Cedars-Sinai’s Maxine Dunitz Neurosurgical Institute.The research could help doctors improve treatments for lung and breast cancers that have metastasized to the brain.Even if a cancer is susceptible

PharmaMicsnoreply@blogger.com0tag:blogger.com,1999:blog-1620737507065600123.post-5099851554729862012010-05-10T12:52:00.000-07:002010-05-10T12:58:25.327-07:00

Kaposi's Sarcoma is a cancer caused by a human herpes virus and is widespread in sub-Saharan Africa, where it is the most common cause of cancer amongst those infected with HIV.Researchers from Leeds' Faculty of Biological Sciences found that a human protein - known as PYM - is hijacked by the virus to help it replicate. A virus-encoded protein, ORF57, interacts with PYM and when this interaction

PharmaMicsnoreply@blogger.com0tag:blogger.com,1999:blog-1620737507065600123.post-34872218302032647422010-05-10T12:42:00.000-07:002010-05-10T12:51:07.948-07:00

The U.S. Food and Drug Administration, FDA, has approved a new oral contraceptive for women called Natazia. The new drug contains two female hormones, estrogen and progestin.Scott Monroe, M.D., director of FDA's Division of Reproductive and Urologic Products reports, “Nearly 12 million women in the United States and more than 100 million women worldwide currently use oral contraceptives. The

PharmaMicsnoreply@blogger.com0tag:blogger.com,1999:blog-1620737507065600123.post-91721514154132455352010-05-10T06:57:00.000-07:002010-05-10T07:03:28.611-07:00

The US Food and Drug Administration (FDA) has approved orphan drug designation for a stem cell therapy in patients with newly diagnosed type 1 diabetes mellitus.The product is an intravenous formulation of adult mesenchymal stem cells (MSCs) that are isolated from the bone marrow of healthy young adult donors, thereby avoiding the controversy associated with embryonic and fetal cell sources. Cell

PharmaMicsnoreply@blogger.com0tag:blogger.com,1999:blog-1620737507065600123.post-38387105361348992112010-05-10T06:51:00.000-07:002010-05-10T06:55:01.188-07:00

Patients treated with the Zilver® PTX™ Drug-Eluting Peripheral Stent maintained clinical improvement at two years, according to interim results from the Zilver® PTX™ Global Registry presented today as a late-breaking clinical trial at the Society for Cardiovascular Angiography and Interventions (SCAI) 33rd Annual Scientific Sessions. The prospective, single-arm study is ongoing to evaluate the

PharmaMicsnoreply@blogger.com0tag:blogger.com,1999:blog-1620737507065600123.post-75386322665801987232010-05-06T23:40:00.000-07:002010-05-06T23:47:24.125-07:00

Even if Janet Smith could give her 13-year-old daughter, Heather, a drug that would let her eat gluten, she wouldn’t necessarily do it.The Brooklin mom has been monitoring everything Heather eats since she was an infant, making her special foods and keeping her on a strict, gluten-free diet. It hasn’t been easy — the slightest trace of gluten can make Heather sick for weeks — but Smith isn’t

PharmaMicsnoreply@blogger.com1tag:blogger.com,1999:blog-1620737507065600123.post-88361454581464879752010-05-06T23:19:00.000-07:002010-05-06T23:36:27.005-07:00

Broad-based health care company Abbott Laboratories (ABT) announced Monday that the U.S. Food and Drug Administration approved its supplemental New Drug Application or sNDA for Creon to include dosing guidance in the prescribing information specific to patients with exocrine pancreatic insufficiency or EPI, a condition of limited production of pancreatic enzymes due to chronic pancreatitis or

PharmaMicsnoreply@blogger.com0tag:blogger.com,1999:blog-1620737507065600123.post-81645314823407423382010-05-06T12:55:00.000-07:002010-05-06T23:14:10.212-07:00

Osiris Therapeutics Inc said it is resuming enrollment of patients in a clinical trial to study its lead drug Prochymal in patients with treatment-resistant Crohn's disease, sending its shares up 5 percent in after-market trade.Data from an interim analysis showed that for the primary endpoint of disease remission, the drug approached statistical significance in the intent to treat population,

PharmaMicsnoreply@blogger.com0tag:blogger.com,1999:blog-1620737507065600123.post-16240336537190416962010-05-04T21:58:00.000-07:002010-05-04T22:03:31.932-07:00

Nymox Pharmaceutical Corp., reported new positive results from a long term outcome study of its lead drug candidate to treat benign prostatic hyperplasia, NX-1207. The study, a part of the Phase 3 trial of the drug, evaluated symptomatic progress of U.S. patients involved in the Phase 1 and Phase 2 studies, initially undertaken in 2003. The inclusion criterion was all subjects enrolled in the

PharmaMicsnoreply@blogger.com0tag:blogger.com,1999:blog-1620737507065600123.post-84698405413375984422010-05-04T21:52:00.000-07:002010-05-04T21:57:11.607-07:00

An experimental weight loss drug that pairs a stimulant with an epilepsy drug helped patients lose weight and keep it off for a year and also lowered blood pressure, a researcher said on Tuesday.A consultant to Mountain View, California-based Vivus Inc said three separate studies showed patients lost more weight when they took the highest doses of Qnexa, which is up for Food and Drug

PharmaMicsnoreply@blogger.com0tag:blogger.com,1999:blog-1620737507065600123.post-35455315709637900852010-05-04T21:47:00.000-07:002010-05-04T21:50:57.572-07:00

Daily application of magnetic stimulation to the brain for about 37 minutes can ease depression in patients who are not responding to antidepressants, researchers reported Monday. The procedure -- in effect, a mild form of electroconvulsive therapy, or ECT, which has been shown to be very effective against severe depression -- has been approved by the Food and Drug Administration since 2008, but

PharmaMicsnoreply@blogger.com0tag:blogger.com,1999:blog-1620737507065600123.post-40811734350683182632010-05-03T23:39:00.000-07:002010-05-03T23:44:18.229-07:00

Children with ADHD who carry a specific type of dopamine receptor gene respond better to the drug methylphenidate (MPH) than those without the genotype, according to new research from Cincinnati Children's Hospital Medical Center.The findings come from the first-ever placebo-controlled pharmacogenetic drug trial for Attention Deficit/Hyperactivity Disorder in school age children to evaluate

PharmaMicsnoreply@blogger.com1tag:blogger.com,1999:blog-1620737507065600123.post-73166506045756887732010-05-03T20:55:00.000-07:002010-05-03T23:24:30.930-07:00

Many families are turning toward to special diets and/or psychotropic medications to help better manage autism spectrum disorder and its symptoms in their children, two new studies show.The CDC estimates that about one in 110 children in the U.S. have an autism spectrum disorder, the umbrella name given to a group of disorders that can range from the mild to the severe that often affect social

PharmaMicsnoreply@blogger.com0tag:blogger.com,1999:blog-1620737507065600123.post-81278066947673954352010-05-03T13:50:00.000-07:002010-05-03T13:58:41.285-07:00

Takeda Pharmaceutical Company Limited (Takeda) announced today that Takeda Global Research & Development Center, Inc., U.S., submitted a New Drug Application (NDA) to the United States Food and Drug Administration (FDA) for azilsartan medoxomil , an angiotensin II receptor blocker (ARB) under investigation for the treatment of hypertension. Discovered by Takeda, azilsartan medoxomil is designed

PharmaMicsnoreply@blogger.com0tag:blogger.com,1999:blog-1620737507065600123.post-26094094776363018192010-05-03T13:10:00.000-07:002010-05-03T13:28:19.735-07:00

Two-year results from phase III clinical trials show the experimental immunosuppressive drug belatacept can better preserve kidney function in kidney transplant recipients while preventing graft rejection when compared with the standard immunosuppressive drug cyclosporine.The two-year results from the three-year BENEFIT (Belatacept Evaluation of Nephroprotection and Efficacy as First-line

PharmaMicsnoreply@blogger.com0tag:blogger.com,1999:blog-1620737507065600123.post-52340638835468692062010-05-03T12:55:00.000-07:002010-05-03T13:06:32.243-07:00

Shares of Pozen Inc. surged more than 21% in the after hours trading session Friday after the U.S. Food and Drug Administration or FDA approved VIMOVO delayed-release tablets for the relief of signs and symptoms of osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis, and to decrease the risk of developing gastric ulcers in patients at risk of developing NSAID-associated gastric

PharmaMicsnoreply@blogger.com0tag:blogger.com,1999:blog-1620737507065600123.post-88839385868956602582010-05-01T01:04:00.000-07:002010-05-01T01:16:27.305-07:00

An experimental drug succeeded in a small clinical trial in bringing about what the researchers called substantial improvements in the behaviors associated with retardation and autism in people with fragile X syndrome, the most common inherited cause of these mental disabilities.The surprising results, disclosed in an interview this week by Novartis, the Swiss pharmaceutical giant that makes the

PharmaMicsnoreply@blogger.com0tag:blogger.com,1999:blog-1620737507065600123.post-10674120209121554052010-05-01T00:56:00.000-07:002010-05-01T01:03:02.737-07:00

Bulking up with anabolic steroids appears to damage and weaken the heart, a new study shows, in principle increasing the odds of heart failure.While it's nothing new that steroids have bad health effects, the new findings show they may be more harmful than previously thought. In heart failure, a weakened heart can't pump enough blood around the body.The study did not find heart failure itself,

PharmaMicsnoreply@blogger.com0tag:blogger.com,1999:blog-1620737507065600123.post-15715524149164134942010-05-01T00:40:00.000-07:002010-05-01T00:49:16.649-07:00

Testing for specific cancer protein markers in lung cancer patients' blood helps find those more likely to respond to Tarceva, a drug sold by Roche and OSI Pharmaceuticals , data showed on Friday.A study presented at the European Lung Cancer Conference in Geneva showed that a relatively simple blood analysis known as a proteomic test can identify patients whose tumours are likely to shrink with

PharmaMicsnoreply@blogger.com0tag:blogger.com,1999:blog-1620737507065600123.post-31722022347403551792010-04-29T22:31:00.000-07:002010-04-29T22:40:12.894-07:00

Lung cancer patients whose tumors over-express a cell surface molecule called CXCR4 do significantly worse than those who do not, Canadian researchers have found. Their work, reported at the 2nd European Lung Cancer Conference in Geneva, highlights the exciting possibility that the molecule could soon become a new target for personalized cancer therapy.CXCR4 is a receptor that is found on the

PharmaMicsnoreply@blogger.com0tag:blogger.com,1999:blog-1620737507065600123.post-82981360051502137492010-04-29T22:23:00.000-07:002010-04-29T22:30:16.692-07:00

Santaris Pharma is close to completing a second phase I study of its microRNA-targeting hepatitis C therapy SPC 3649, and expects to move the drug into phase II development later this year, a company official told RNAi News.The official, CSO Henrik Orum, also said Santaris has dropped its near-term plan to seek a partner for the therapy, which it will instead carry on its own at least through the

PharmaMicsnoreply@blogger.com0tag:blogger.com,1999:blog-1620737507065600123.post-59261257289457402562010-04-29T22:16:00.000-07:002010-04-29T22:43:14.388-07:00

Dendreon Corp. won approval for its only product, the prostate cancer vaccine Provenge, concluding a three-year battle with U.S. regulators to introduce the first therapy to train the body’s immune system to destroy tumors.Provenge may reap annual sales of $4.3 billion by 2020, said George Farmer, a Canaccord Adams Inc. analyst in New York. Its clearance will also benefit more than a dozen other

PharmaMicsnoreply@blogger.com0tag:blogger.com,1999:blog-1620737507065600123.post-54082901738980212942010-04-29T22:06:00.000-07:002010-04-29T22:12:38.498-07:00

A scientific study provided support on Friday for a way of fighting heart disease being pioneered by GlaxoSmithKline, likely to boost interest in drugs that target an enzyme involved in clogging arteries.A study published in The Lancet medical journal suggests that the enzyme, known as lipoprotein-associated phospholipase A2, or Lp-PLA2, plays as much of a role in the risk of heart disease as

PharmaMicsnoreply@blogger.com0tag:blogger.com,1999:blog-1620737507065600123.post-25738719979101636982010-04-29T09:59:00.000-07:002010-04-29T10:14:36.836-07:00

Package inserts for all of the approved protease inhibitors (PIs) used to treat HIV have been updated to reflect important drug-drug interactions, according to an April 27 e-mail announcement from the U.S. Food and Drug Administration.Drug-drug interactions are a common obstacle among people living with HIV receiving antiretroviral therapy. This is especially true for those using PIs, widely

PharmaMicsnoreply@blogger.com0tag:blogger.com,1999:blog-1620737507065600123.post-83469063903942447502010-04-29T08:01:00.000-07:002010-04-29T08:09:50.068-07:00

In the article titled “Pharmaceutical injury alert: FDA slams Pfizer with warnings for deadly clinical trials,” posted on April 23, 2010, it was incorrectly reported that participants of a drug trial died. Twenty-six pediatric patients received overdoses of a psychiatric drug in 2006, and three more overdoses occurred in 2007; the overdoses did not result in any fatalities.The U.S. Food and Drug

PharmaMicsnoreply@blogger.com0tag:blogger.com,1999:blog-1620737507065600123.post-79829224432679290552010-04-29T07:51:00.000-07:002010-04-29T07:59:17.338-07:00

People with a common, obesity-related liver disease that has no known treatment got a surprising benefit from vitamin E pills, researchers reported Wednesday.It appears to be the first time that a vitamin supplement has been shown to help treat a major ailment not caused by a nutrient deficiency. However, doctors warned that this does not mean people should automatically take vitamin E since some

PharmaMicsnoreply@blogger.com0tag:blogger.com,1999:blog-1620737507065600123.post-31693172745864023262010-04-29T07:35:00.000-07:002010-04-29T07:50:00.500-07:00

A study shows that combining the drug ranibizumab, or Lucentis, with laser therapy is twice as effective at improving vision for those with diabetic macular edema.For the first time in a quarter of a century, researchers have identified a new treatment for diabetic macular edema, a potentially blinding disorder that affects about 1 million Americans, researchers said Tuesday.The treatment uses a

PharmaMicsnoreply@blogger.com0tag:blogger.com,1999:blog-1620737507065600123.post-50152602962139879182010-04-27T23:03:00.000-07:002010-04-27T23:15:24.323-07:00

As many as one in three men suffer from premature ejaculation (PE) at some point in their life. A new prescription drug, Priligy, may help alleviate the effects of this sexual dysfunction, at least for PE sufferers who live in the UK.If taken 1 to 3 hours before sex, Priligy can make a man last 2 to 3 times longer during intercourse. With that said, the average time gained is only two minutes.

PharmaMicsnoreply@blogger.com0tag:blogger.com,1999:blog-1620737507065600123.post-55757254484483085972010-04-27T22:56:00.000-07:002010-04-27T23:01:29.409-07:00

Inherited diseases such as cystic fibrosis can be caused by genetic "nonsense mutations" that disrupt the way human cells make proteins. David Bedwell, Ph.D., a professor in the University of Alabama at Birmingham (UAB) Department of Microbiology, says scientists are now closer to producing drugs that will fix this disruption and drastically improve treatment of genetic disease.Bedwell is a

PharmaMicsnoreply@blogger.com0tag:blogger.com,1999:blog-1620737507065600123.post-17344253325141305902010-04-27T22:44:00.000-07:002010-04-27T22:50:39.521-07:00

Covidien , a leading global provider of healthcare products, has introduced Pennsaid (diclofenac sodium topical solution) 1.5% w/w to the U.S. market. पेंन्सैद is the only FDA-approved topical non-steroidal anti-inflammatory drug (NSAID) in a vehicle solution containing dimethyl sulfoxide (DMSO), a known penetrating agent. It is indicatedfor treatment of the signs and symptoms of osteoarthritis

PharmaMicsnoreply@blogger.com0tag:blogger.com,1999:blog-1620737507065600123.post-37431950745079880062010-04-27T22:25:00.000-07:002010-04-27T22:32:19.009-07:00

Drugmaker Merck & Co. said Monday it has bought rights to help market what would be the first anti-inflammatory pill for a chronic lung condition, just a few days after European regulators recommended approval there.The deal gives Merck rights to jointly market Daxas, made by Swiss drugmaker Nycomed, for chronic obstructive pulmonary disease in Canada and several European countries. Merck, based

PharmaMicsnoreply@blogger.com0tag:blogger.com,1999:blog-1620737507065600123.post-31793669330239832022010-04-27T22:14:00.000-07:002010-04-27T22:24:02.978-07:00

NexMed, Inc. , a specialty CRO with a pipeline of products based on the NexACT technology, today announced that the U.S. Food & Drug Administration (FDA) has cleared the Company to proceed with the proposed Phase 2 trial of PrevOnco , its proprietary cancer treatment for patients with advanced, unresectable hepatocellular carcinoma (HCC), or liver cancer.The FDA granted PrevOnco orphan drug

PharmaMicsnoreply@blogger.com0tag:blogger.com,1999:blog-1620737507065600123.post-10067418711028134002010-04-26T14:59:00.000-07:002010-04-26T15:05:43.879-07:00

A number of leading drug makers used this year's meeting of the American Academy of Neurology to present new data for promising pipeline candidates. Despite promising results, however, Datamonitor believes that the epilepsy drugs will struggle to find their place in the market. Moreover, the positive Phase II data for Baxter’s potential Alzheimer’s therapy Gammagard do not guarantee later

PharmaMicsnoreply@blogger.com0tag:blogger.com,1999:blog-1620737507065600123.post-21750161563916783382010-04-26T14:43:00.000-07:002010-04-26T14:56:41.279-07:00

Celator Pharmaceuticals today announced data from animal studies demonstrating the superior bone marrow uptake of CPX-351 (Cytarabine:Daunorubicin) Liposome Injection, its lead clinical-stage program, as well as the enhanced circulation kinetics and efficacy of its preclinical hydrophobic docetaxel prodrug nanoparticle (HDPN) formulation were presented at the 101st Annual Meeting of the American

PharmaMicsnoreply@blogger.com0tag:blogger.com,1999:blog-1620737507065600123.post-16039006790202846872010-04-26T14:26:00.000-07:002010-04-26T14:35:51.586-07:00

NMS Labs launches another unique test suitable for the evaluation of toxicity vs. efficacy, the potential for physicians to establish therapeutic drug monitoring (TDM) of individual patients, and the assessment of drug diversion of a new pain management drug therapy.NMS Labs is the only known commercial laboratory to develop and perform a clinical quantitative assay for Milnacipran (Savella®)

PharmaMicsnoreply@blogger.com0tag:blogger.com,1999:blog-1620737507065600123.post-45990124012345556602010-04-26T14:15:00.000-07:002010-04-26T14:22:19.158-07:00

Polaris Group scientists and university collaborators reported at the American Association for Cancer Research (AACR), that a number of different cancers have a deficiency in a specific enzyme, argininosuccinate synthetase (ASS), which allows pegylated arginine deiminase (ADI-PEG 20) to inhibit cancer cell growth."Polaris has been testing this drug in melanoma patients and patients with

PharmaMicsnoreply@blogger.com0tag:blogger.com,1999:blog-1620737507065600123.post-75258562276971742122010-04-25T15:01:00.000-07:002010-04-25T21:14:36.113-07:00

Scandinavian researchers writing in The Lancet gave a warm review to an investigational drug for migraine, but patients in the United States, at least, will have a wait before it reaches them.Merck manufactures the drug, called telcagepant, and was initially expected to seek approval from the U.S. Food and Drug Administration last year.An online Lancet review by researchers from Sweden and Norway

PharmaMicsnoreply@blogger.com0tag:blogger.com,1999:blog-1620737507065600123.post-12238990156081960222010-04-25T06:45:00.001-07:002010-04-25T06:50:04.886-07:00

Women at high risk can take either drug as preventive therapy, researchers in a seven-year study say.Two drugs taken by women at high risk for breast cancer — tamoxifen and raloxifene — both reduce the risk of the disease by about 50% in high-risk post-menopausal women while they are taking the medications, researchers said Monday. The benefits of raloxifene fall off more quickly once women stop

PharmaMicsnoreply@blogger.com0tag:blogger.com,1999:blog-1620737507065600123.post-62625702729646137402010-04-25T06:23:00.000-07:002010-04-25T06:53:14.521-07:00

The cancer drug cyclophosphamide activates a viral infection that helps anti-viral medications eliminate a virus-linked cancer, says a new study.The drug is used to treat Burkitt lymphoma, an aggressive, fast-growing type of non-Hodgkin lymphoma that often occurs in children. In Africa, the cancer is caused by the Epstein-Barr virus (EBV), which typically remains dormant inside tumor cells.This

PharmaMicsnoreply@blogger.com0tag:blogger.com,1999:blog-1620737507065600123.post-6971005428586727022010-04-23T07:39:00.000-07:002010-04-23T07:44:02.923-07:00

Researchers announced positive results from tests of an experimental anti-cancer drug known as NGR-hTNF in controlling the cancer of patients with malignant pleural mesothelioma. Mesothelioma is an incurable cancer of the lining of the lung associated with asbestos exposure.NGR-hTNF is a novel drug compound that includes a peptide—a chain of amino acids—that homes in on cancer cells—and a type of

PharmaMicsnoreply@blogger.com0tag:blogger.com,1999:blog-1620737507065600123.post-64671386013468910402010-04-23T07:26:00.000-07:002010-04-23T07:35:52.844-07:00

Metformin, a medication commonly used in the treatment of type 2 diabetes, may reduce the risk of breast cancer when used for more than five years, according to a new study published by the American Diabetes Association. The study adds fuel to increasing evidence of metformin's potential anti-cancer effects.The study, led by Dr. Christoph R. Meier of Switzerland, followed more than 1,000 women in

PharmaMicsnoreply@blogger.com0tag:blogger.com,1999:blog-1620737507065600123.post-86005826177767710072010-04-23T07:13:00.000-07:002010-04-23T07:19:39.816-07:00

Pfizer Inc said on Thursday it has discontinued a late stage liver cancer study of its drug Sutent because of high incidence of serious adverse events suffered by patients taking the medicine.Following a review by the independent Data Monitoring Committee the trial was halted over safety issues, Pfizer said.Sutent is already approved to treat advanced kidney cancer and gastrointestinal stromal

PharmaMicsnoreply@blogger.com0tag:blogger.com,1999:blog-1620737507065600123.post-14597979078620302632010-04-23T07:03:00.000-07:002010-04-23T07:08:13.149-07:00

Novo Nordisk's new diabetes drug Victoza proved more effective than Merck & Co's Januvia in a head-to-head study, boosting prospects for a product that has got off to a strong start in key markets.Daily injections of both high- and low-dose Victoza reduced blood sugar levels by more than a daily tablet of Januvia in people with type 2 diabetes who had not responded adequately to the older drug

PharmaMicsnoreply@blogger.com0tag:blogger.com,1999:blog-1620737507065600123.post-21855669277753263552010-04-23T06:50:00.000-07:002010-04-23T06:54:55.576-07:00

A new drug for malaria proved as effective as Novartis's leading treatment Coartem in a clinical trial, researchers said on Friday, although an outside expert said the findings had limitations.Coartem is the current "gold standard" for people infected with the mosquito-borne disease. The two-in-one Novartis drug needs to be taken twice a day and requires a fatty diet for optimum

PharmaMicsnoreply@blogger.com0tag:blogger.com,1999:blog-1620737507065600123.post-6800484851136479672010-01-13T13:19:00.000-08:002010-01-13T13:20:28.168-08:00

FDA officials have recently approved a drug known as Acterma for treating moderate to severe forms of rheumatoid arthritis in patients non-responsive to TNF inhibitors.Rheumatoid arthritis, an autoimmune disease that causes chronic inflammation of the joints, is typically a progressive illness, leading to long-term destruction and functional disability.There is no known cure for the condition;

PharmaMicsnoreply@blogger.com2tag:blogger.com,1999:blog-1620737507065600123.post-21476620408747609322010-01-10T07:40:00.000-08:002010-01-10T07:42:33.990-08:00

An anti-depressant drug developed over 40-years ago has been found to dull, even reverse muscle enlargement and weakened pumping function connected to heart failure, in animal experiments carried out by a team of researchers from Johns Hopkins.Publishing their report in the journal Circulation Research, the heart experts describe how the no longer in use anti-depressant clorgyline, blocked enzyme

PharmaMicsnoreply@blogger.com0tag:blogger.com,1999:blog-1620737507065600123.post-67423429805573629542010-01-10T07:35:00.000-08:002010-01-10T07:38:21.152-08:00

UnknownIt's January in Portland, dark outside more than half the time. The only glimpse of color comes from those Hawaiian Airlines billboards around town, advertising flights to tropical islands that feel financially out of reach.An antidepressant sounds good right about now. Maybe a few bottles of antidepressants, carried close in a fanny pack and popped like mints until the weather and economy

PharmaMicsnoreply@blogger.com0tag:blogger.com,1999:blog-1620737507065600123.post-27955813595148456132010-01-10T07:20:00.000-08:002010-01-10T07:34:51.341-08:00

Lung cancer is the leading cause of cancer-related mortality in both men and women in the United States and throughout the world. Non-small cell lung cancer (NSCLC) accounts for approximately 85% of all lung cancers. Sadly, most cases of lung cancer are diagnosed at an advanced stage, conferring a poor prognosis.Should Phase III results be positive, the next step is filing a New Drug Application,

PharmaMicsnoreply@blogger.com0tag:blogger.com,1999:blog-1620737507065600123.post-84795239221841202852010-01-10T07:08:00.000-08:002010-01-10T07:19:55.536-08:00

Federal regulators have approved a new class of rheumatoid arthritis drug created by South San Francisco's Genentech.The drug, called Actemra, is the first arthritis treatment to operate by blocking the activity of a protein called interleukin-6 that, when overly abundant in the body, causes inflammation in the joints associated with arthritis। The Food and Drug Administration approved the drug

PharmaMicsnoreply@blogger.com0tag:blogger.com,1999:blog-1620737507065600123.post-60405645041021484632010-01-02T13:14:00.000-08:002010-01-02T13:18:56.813-08:00

Biodel, Inc. announced today that it has submitted a new drug application (NDA) to the U.S. Food and Drug Administration for clearance to market VIAject® as a treatment for diabetes.VIAject® is Biodel’s proprietary formulation of recombinant human insulin that is designed to be absorbed into the blood faster than currently marketed rapid-acting insulin analogs. It is Biodel’s most advanced

PharmaMicsnoreply@blogger.com0tag:blogger.com,1999:blog-1620737507065600123.post-73218636524207431032010-01-02T13:03:00.000-08:002010-01-02T13:14:01.250-08:00

A new public/private research program will study the effects of prescription medications used during pregnancy, U.S. researchers say.The researchers from the U.S. Food and Drug Administration, the HMO Research Network Center for Education and Research in Therapeutics, Kaiser Permanente's multiple research centers and Vanderbilt University say very few clinical trials test the safety of

PharmaMicsnoreply@blogger.com1tag:blogger.com,1999:blog-1620737507065600123.post-73546848244532637042009-12-27T00:14:00.000-08:002009-12-27T00:54:47.987-08:00

A New Drug Application for the pancreatic enzyme replacement therapy agent for pancreatic exocrine insufficiency, SA-001 (API name: Pancrelipase) that Solvay Seiyaku K. K. co-developed with Eisai Co., Ltd. was submitted by Solvay Seiyaku on December 22, 2009 in Japan.The agent is a high performance, acid resistant enteric-coated pancreatic enzyme obtained by formulating highly purified

PharmaMicsnoreply@blogger.com0tag:blogger.com,1999:blog-1620737507065600123.post-65906467951354074352009-12-22T05:07:00.000-08:002009-12-22T05:15:25.270-08:00

Azaya Therapeutics, Inc. announced today that the Food and Drug Administration (FDA) has approved its Investigational New Drug (IND) application for its lead product "ATI-1123," a novel and improved formulation of Taxotere® (docetaxel), a leading chemotherapy drug with worldwide annual sales of over $2.8 billion.Azaya’s Phase I clinical study will now open for enrollment at two premier cancer

PharmaMicsnoreply@blogger.com0tag:blogger.com,1999:blog-1620737507065600123.post-62397224956709119342009-12-22T05:00:00.000-08:002009-12-22T05:06:34.888-08:00

A radical new drug used to treat patients suffering painful sensitivity to sunlight could prevent skin cancer or be copied by the tanning industry.The breakthrough drug Afamelanotide, developed by a Melbourne company, has been successfully tested for 12 months on 101 people worldwide, including six Melburnians, all with the incurable genetic skin disorder EPP.The illness leaves suffers with

PharmaMicsnoreply@blogger.com0tag:blogger.com,1999:blog-1620737507065600123.post-49674655453335062382009-12-22T04:54:00.000-08:002009-12-22T05:00:03.697-08:00

An experimental new drug could be more effective than existing drugs against swine flu and bird flu, a UW-Madison researcher found.The drug, T-705, or favipiravir, was previously found to be effective against swine flu, or H1N1। Now Yoshihiro Kawaoka, a virologist at the university, has shown that the drug protects mice against bird flu, or H5N1।Kawaoka and other flu experts consider bird flu to

PharmaMicsnoreply@blogger.com0tag:blogger.com,1999:blog-1620737507065600123.post-22796176779045983162009-12-11T16:41:00.001-08:002009-12-11T16:41:00.175-08:00

The drug Sprycel, approved for use by the U.S. Food and Drug Administration in patients with chronic myeloid leukemia, significantly inhibited the growth and invasiveness of ovarian cancer cells and also promoted their death, a study by researchers with UCLA's Jonsson Comprehensive Cancer Center found.The drug, when paired with a chemotherapy regimen, was even more effective in fighting ovarian

PharmaMicsnoreply@blogger.com0tag:blogger.com,1999:blog-1620737507065600123.post-5119382059582927682009-12-11T13:37:00.000-08:002009-12-11T13:37:00.216-08:00

Medications frequently given to cancer patients to reduce their risk of anemia are associated with an increased risk of deep vein thrombosis or pulmonary embolism, according to new research led by Dawn Hershman, M.D, M.S., co-director of the breast cancer program at the Herbert Irving Comprehensive Cancer Center at NewYork-Presbyterian Hospital/Columbia University Medical Center. The findings

PharmaMicsnoreply@blogger.com0tag:blogger.com,1999:blog-1620737507065600123.post-68680495362696670112009-12-11T09:32:00.000-08:002009-12-11T09:32:00.566-08:00

Aastrom Biosciences, Inc. , a leading developer of autologous cell products for the treatment of chronic cardiovascular diseases, today announced that the Company will initiate its second clinical trial for the treatment of dilated cardiomyopathy (DCM), a severe disease associated with chronic heart failure, after a positive 30-day review of Aastrom's Investigational New Drug (IND) submission by

PharmaMicsnoreply@blogger.com0tag:blogger.com,1999:blog-1620737507065600123.post-57725054960224661702009-12-11T05:27:00.000-08:002009-12-11T05:27:00.579-08:00

Mylan Inc. today announced that its privately held Indian subsidiary, Matrix Laboratories Limited, has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Lansoprazole Delayed-release (DR) Capsules, 15 mg and 30 mg. This product is shipping immediately and will be sold under the Mylan Pharmaceuticals brand.Lansoprazole DR

PharmaMicsnoreply@blogger.com0tag:blogger.com,1999:blog-1620737507065600123.post-44903376626037325452009-12-11T02:24:00.000-08:002009-12-11T02:24:00.117-08:00

Scientists from the Imperial College of London have identified a promising new drug for the treatment of an aggressive form of lung cancer; small cell lung cancer.Small cell lung cancer forms about 15-20% of the total cases of lung cancer. It is the most aggressive form of cancer that occurs within the lungs and grows and spreads quickly, most often to the brain, liver and bones.Prognosis is poos

PharmaMicsnoreply@blogger.com0tag:blogger.com,1999:blog-1620737507065600123.post-37171724811705548942009-12-07T06:14:00.000-08:002009-12-07T06:20:39.564-08:00

Researchers from Dana-Farber Cancer Institute have found that a new three-drug combination can effectively treat patients newly diagnosed with multiple myeloma, a cancer of white blood cells in the bone marrow.The three-drug combination has shown in a phase 1/2 clinical trial that it is a ‘highly effective regimen’ in the treatment of this form of cancer.Paul G. Richardson, of Dana-Farber, who

PharmaMicsnoreply@blogger.com0tag:blogger.com,1999:blog-1620737507065600123.post-75504778550066616532009-12-07T05:06:00.000-08:002009-12-07T06:13:34.153-08:00

A new study provides welcome news for patients with a common clotting disorder known as venous thromboembolism (VTE).The condition is estimated to impact 62,000 Canadians and half-a-million Americans every year, and occurs when an abnormal clot forms in a vein and restricts the flow of blood, causing pain and swelling। In some cases, the clot may detach from its point of origin and travel through

PharmaMicsnoreply@blogger.com0tag:blogger.com,1999:blog-1620737507065600123.post-21648299445926401872009-11-11T12:10:00.000-08:002009-11-11T12:23:03.847-08:00

An FDA panel is looking into the possibility that a new drug named Ampriva is helping people with Multiple Sclerosis. The drug is a reconfigured form of fampridine, which was originally used as a bird poison.The Food and Drug Administration is looking at reports that the medication has helped people with MS actually walk with the help of the drug.It's possible that the FDA will put this on the

PharmaMicsnoreply@blogger.com0tag:blogger.com,1999:blog-1620737507065600123.post-47493077625928865792009-11-08T05:08:00.000-08:002009-11-08T05:19:39.897-08:00

The study bolstered evidence of a link between the drug, pulled from the market in June, and inflammatory bowel disease. No medication is as effective in treating severe cases of acne.Teenagers and young adults suffering from severe, scarring acne may ultimately lose the most effective treatment for the condition.Swiss-based Roche Holding quietly pulled its blockbuster drug Accutane off the

PharmaMicsnoreply@blogger.com0tag:blogger.com,1999:blog-1620737507065600123.post-43229928378330238422009-11-06T23:27:00.000-08:002009-11-06T23:27:01.960-08:00

A Dutch study has recently confirmed that an experimental medicine targeted at human papillomavirus (HPV) can prove much effective in curbing the growth of precancerous tumours in the vulva. The vaccine has been found effective to stop their growth, thereby preventing them from turning into cancerous malignancies.Experts have been saying that Gardasil and Cervarix, two popular HPV medicines,

PharmaMicsnoreply@blogger.com0tag:blogger.com,1999:blog-1620737507065600123.post-22477899397463681542009-11-06T20:24:00.000-08:002009-11-06T20:24:02.515-08:00

A "miracle" Australian baby has become the first person cured of a rare and deadly brain-melting condition after doctors gambled on an experimental German drug tested only on mice, they said Thursday.The child, known only as "Baby Z," was facing a painful death of seizures and brain damage from molybdenum cofactor deficiency, a genetic defect which causes a build-up of toxic sulphite and usually

PharmaMicsnoreply@blogger.com0tag:blogger.com,1999:blog-1620737507065600123.post-63647358860875359562009-11-06T16:19:00.000-08:002009-11-06T16:19:00.343-08:00

Scientists have identified a chemical cousin of the common antibiotic tetracycline that might be useful in treating spinal muscular atrophy (SMA), a currently incurable disease that is the leading genetic cause of death in infants.The finding is based on a study conducted by Adrian Krainer, Ph.D., of Cold Spring Harbor Laboratory (CSHL) and scientists from Paratek Pharmaceuticals and Rosalind

PharmaMicsnoreply@blogger.com0tag:blogger.com,1999:blog-1620737507065600123.post-28021696644198997892009-11-06T10:10:00.000-08:002009-11-06T10:18:37.772-08:00

Athena Gurno thought her allergies were acting up when she started coughing in early October. But within days, Ms. Gurno, the 30-year-old mother of a young girl, was in a Seattle hospital, close to death from the H1N1 flu.Desperate, her doctors tried a still-experimental drug called peramivir. After getting her second dose, Ms. Gurno started to recover, though she is still in intensive care,

PharmaMicsnoreply@blogger.com0